CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company
TriSalus Life Sciences, Inc.
Sign in to watch- Ticker
- TLSI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853009869
- Phone
- 415 336 8917
- Business address
- 6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
- Former names
- MedTech Acquisition Corp, MedTech Acquisition Corporation
Securities
- TLSI Common Stock Nasdaq
- TLSIW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,113
- in 3 filings
Net −$4,113. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-27 | Young James Emmett Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-01-27 | Devlin Jodi Chief of COMMERC. OPERATIONS | Grant or award | +10,625 | 28,125 | ||
| 2025-01-27 | Devlin Jodi Chief of COMMERC. OPERATIONS | Grant or award · Employee Stock Option (right to buy) | +63,750 | 63,750 | ||
| 2025-01-27 | Marshak Richard Chief Commercial Officer | Grant or award | +12,500 | 46,626 | ||
| 2025-01-27 | Marshak Richard Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-01-27 | Stevens Jennifer CHIEF REGULATORY OFFICER | Grant or award | +10,625 | 43,408 | ||
| 2025-01-27 | Stevens Jennifer CHIEF REGULATORY OFFICER | Grant or award · Employee Stock Option (right to buy) | +63,750 | 63,750 | ||
| 2025-01-02 | MATLIN DAVID J Director | Grant or award | +10,040 | 941,944 | ||
| 2025-01-02 | Hyveled Liselotte Director | Grant or award | +10,040 | 10,040 | ||
| 2024-12-17 | Wahlstrom Mats Director | Grant or award | +25,188 | $3.97 | $100K | 40,915 |
| 2024-12-17 | Frankenius Equity AB 10% owner | Purchase | +62,972 | $3.97 | $250K | 6,230,748 |
| 2024-12-10 | Desai Arjun JJ Director | Sale | −30,000 | $3.69 | $111K | 247,127 |
| 2024-11-22 | Wahlstrom Mats Director | Purchase | +5,000 | $4.55 | $23K | 15,727 |
| 2024-11-21 | Wahlstrom Mats Director | Purchase | +8,687 | $4.44 | $39K | 10,727 |
| 2024-11-20 | Wahlstrom Mats Director | Purchase | +2,040 | $4.16 | $8K | 2,040 |
| 2024-11-14 | Marshak Richard SR.VP, CORP. DEV. & STRATEGY | Grant or award | +6,875 | 34,126 | ||
| 2024-11-14 | Marshak Richard SR.VP, CORP. DEV. & STRATEGY | Grant or award · Employee Stock Option (right to buy) | +41,250 | 41,250 | ||
| 2024-10-05 | Cox Bryan F. CHIEF SCIENTIFIC & MANUFACT. | Sale | −314 | $4.44 | $1K | 86,382 |
| 2024-09-13 | Szela Mary T CEO AND PRESIDENT | Purchase | +1,295 | $4.83 | $6K | 378,677 |
| 2024-09-13 | Szela Mary T CEO AND PRESIDENT | Purchase | +6,000 | $5.00 | $30K | 384,677 |
Page 7 of 9 · 161 trades